Psychosocial factors: role in cardiac risk and treatment strategies.
Recent epidemiologic research has identified several psychosocial factors that impact unfavorably on prognosis among patients with established coronary heart disease (CHD). Several biologic and behavioral characteristics have been identified in patients with these psychosocial risk factors that are biologically plausible mediators of their adverse impact on prognosis. Several small-scale clinical trials offer encouraging evidence that both behavioral and pharmacologic interventions have the potential to ameliorate the health-damaging effects of psychosocial risk factors in patients with CHD. In this article we review the evidence on these points and offer recommendations as to how incorporation of this new knowledge into clinical care of the patient with CHD can lead to reduced mortality and morbidity rates in this population.
Williams
R B
RB
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Littman
A B
AB
D001521:Behavior Therapy; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000523:psychology / Q000628:therapy; D006801:Humans; D007389:Internal-External Control; D011379:Prognosis; D011602:Psychophysiologic Disorders / Q000523:psychology*; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012307:Risk Factors; D012931:Social Environment; D013315:Stress, Psychological / Q000150:complications
D011619:Psychotropic Drugs